Symposium 2011 Video

John Marshall, Keynote Speaker
Fighting a Smarter War Against Cancer: Linking Policy to the Patient

Since 2009, the Ruesch Center has hosted a series of multidisciplinary symposia to engage the public in a discussion of the future of cancer research and the use of personalized medicine as the key to a cure. While the earlier events focused mainly on the science behind personalized medicine, the 2011 symposium, "Fighting a Smarter War Against Cancer: Linking Policy to the Patient," seeks to drive the conversation around the impact of health care reform and the concept of value in medicine.

Videos by subject and speaker from Fighting a Smarter War Against Cancer: Linking Policy to the Patient, held on December 1, 2, and 3, 2011, are available online.


Day 1: Health Care Reform: Opportunity or Sacrifice?

Welcome and Introductory Remarks

John Marshall, MD
Director, Ruesch Center for the Cure of GI Cancers
Chief, Division of Hematology/Oncology
Associate Director, Georgetown Lombardi Comprehensive Cancer Center

The Honorable Steny Hoyer
Representative, 5th Congressional District of Maryland and House Democratic Whip, 112th Congress

Louis M. Weiner, MD
Director
Georgetown Lombardi Comprehensive Cancer Center
Georgetown University Medical Center

 

Schafer Memorial Lecture/Discussion

Moderator: M. Gregg Bloche, MD, JD
Professor of Law, Georgetown University Law Center; Co-Director, Georgetown-Johns Hopkins Joint Program in Law and Public Health

David Kerr, MD (Presenter of the 2011 Schafer Memorial Lecture)
Professor of Cancer Medicine, Nuffield Department, Clinical and Laboratory Sciences, University of Oxford; Adjunct Professor of Medicine, Weill-Cornell College of Medicine, New York; President, European Society of Medical Oncology

Panelists:
Mace Rothenberg, MD
Senior Vice President, Clinical Development & Medical Affairs, Oncology Business Unit, Pfizer, Inc.

Gilad Gordon, MD, MBA
President, ORRA Group, LLC

Martin Brown, PhD
Chief, Health Services and Economics Branch, Applied Research Program, National Cancer Institute, U.S. National Institutes of Health

 

Day 2: Defining Value in Cancer Care

Cancer Care 2011: The Cost of Care in the U.S. and its Impact

M. Gregg Bloche, MD, JD
Professor of Law, Georgetown University Law Center,
Co-Director, Georgetown-Johns Hopkins Joint Program in Law and Public Health


Bending the Cost Curve in Cancer

Thomas Smith, MD, FACP
Director of Palliative Medicine, Johns Hopkins Medical Institutions
Professor of Oncology, Sidney Kimmel Comprehensive Cancer Center


The Gatekeepers: Safety and Efficacy vs. Value

Gregory Reaman, MD
Associate Director, Office of Oncology Drug Products, Office of New Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration


The Impact of Guideline Based Medicine, the NCCN Process and Perspective

Jordan Berlin, MD
Professor of Medicine, Vanderbilt University School of Medicine
Clinical Director, GI Oncology Program & Medical Director, Clinical Trials Shared Resources, Vanderbilt-Ingram Cancer Center


The Gatekeepers: Roundtable Discussion

Moderator: M. Gregg Bloche, MD, JD
Professor of Law, Georgetown University Law Center
Co-Director, Georgetown-Johns Hopkins Joint Program in Law and Public Health


Measuring Value in Cancer: U.S. & Global Perspectives Roundtable Discussion

Moderator:
Arnold L. Potosky, PhD
Director of Health Services Research
Georgetown Lombardi Comprehensive Cancer Center

Panelists:
Paul Wallace, MD
Senior Vice President and Director
Center for Comparative Effectiveness Research
The Lewin Group

Mona Sabharwal, PharmD
Executive Director
Pan-Canadian Oncology Drug Review

Arthur "Art" Small, MD
Head, Oncology Outcomes Research
U.S. Medical Affairs, Biometrics, Health Outcomes & Payer Support, Genentech, Inc.

Margaret "Mimi" Mahon, PhD, RN, FAAN
Palliative Care Nurse Practitioner
Associate Professor, School of Nursing, George Mason University, College of Health & Human Services


The Stakeholders' Perspectives: What Do We Want in the Clinic? Roundtable Discussion

Moderator:
Ellen V. Sigal, PhD
Chairperson and Founder
Friends of Cancer Research
Panelists and Ruesch Center Advocacy Board Members:

Carolyn R. "Bo" Aldige
President and Founder
Prevent Cancer Foundation

Carlea Bauman
President
Fight Colorectal Cancer

Julie M. Fleshman, JD, MBA
President and Chief Executive Officer
Pancreatic Cancer Action Network

Gilad S. Gordon, MD, MBA
President
ORRA Group, LLC

Jasmine Greenamyer
Chief Operating Officer
Colon Cancer Alliance

Mace L. Rothenberg, MD
Senior Vice President
Clinical Development & Medical Affairs
Oncology Business Unit, Pfizer, Inc.

Michael Sapienza
Executive Director and Founder
Chris4Life Colon Cancer Foundation

Kim Thiboldeaux
President and Chief Executive Officer
Cancer Support Community